March Power Hour – Drug Repurposing for Rare Disease

PTEN UK and Ireland patient group have joined forces with a range of PTEN specialists to bring you a collection of webinars to inform you on your PTEN journey. There will be a different specialist each month.

This month we will be speaking with Paul Elvin (PTEN Research) and Priyanka Tibarewal (UCL and PTEN-UKI), about drug repurposing for PHTS.

Click here now to get your tickets for the event.

Priyanka is a PHTS researcher at UCL London. Priyanka’s research focuses on doing pre-clinical studies for repurposing drugs for PHTS and she will talk about the studies done by her team at UCL with a focus on a recent study using Rapamycin (Sirolimus)

Paul, prior to joining the Foundation in 2019, was a Principal Scientist at AstraZeneca where he worked for almost 30 years in oncology drug discovery, working on a number of projects including Akt and PI3K that are of interest for PHTS. Since joining the Foundation, Paul has helped establish collaborations with research organisations and academic groups that are evaluating a number of drugs to determine their potential as treatments for PHTS. This talk will discuss the challenges of drug repurposing in a rare disease and the progress that has been made over the last few years that we hope will provide the rationale for clinical studies.